The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Pfizer COVID-19 Vaccine Information
Recommendations
CDC Resources
VIS Information for COMIRNATY
Because the Pfizer COVID-19 vaccine for 12 years and older (COMIRNATY) has been approved for a Biologics License Application (BLA), a vaccine information statement (VIS) must be provided to patients when COMIRNATY (2024-2025 formula) is administered to this age group.
Note: The 2023-2024 formula vaccine is no longer authorized for use in the United States. VIS sheets for the 2024-2025 formula will be posted here when they are updated by the CDC.
COVID-19 2023-2024 Vaccine Information Sheet (VIS) 10/19/2023
COVID-19 2023-2024 Vaccine Information Sheet (VIS) SPANISH
Package Insert - COMIRNATY (fda.gov) 2024-2025 Formula UPDATED 8/23/2024 for 2024-2025 Year Formula
EUA Fact Sheet for Healthcare Professionals
- Pfizer-BioNTech 2024-2025 Formula COVID-19 Vaccine EUA Healthcare Professionals 6m-11y UPDATED 8/23/2024 for 2024-2025 Year Formula
EUA Fact Sheet for Recipients & Caregivers
- Pfizer-BioNTech 2024-2025 Formula COVID-19 Vaccine EUA Recipients and Caregivers 6m-11y UPDATED 8/23/2024 for 2024-2025 Year Formula
Important: Print and provide the above EUA Fact Sheet to each COVID-19 vaccine recipient/caregiver in Michigan for this age group.
This version includes the information statement about the MCIR (as indicated in Michigan VISs). Per state law, patients/parents must be informed about MCIR.